Understanding changes in GABA neurons related to schizophrenia
Deciphering the GABA neuron alterations in schizophrenia
This study is looking at how changes in certain brain cells called GABA neurons might affect thinking and memory in people with schizophrenia, hoping to uncover new insights that could help improve understanding and treatment of the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10545717 on NIH RePORTER |
What this research studies
This research investigates how alterations in GABA neurons contribute to cognitive dysfunction in individuals with schizophrenia. By examining the levels of GAD67 mRNA and protein in specific types of GABA neurons, the study aims to identify which neurons are affected and how these changes impact brain function. The research utilizes advanced techniques to profile GABA neuron subtypes in the human brain, which could lead to a better understanding of the neural circuitry involved in schizophrenia. Patients may benefit from insights gained into the biological mechanisms underlying their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with schizophrenia who may be experiencing cognitive dysfunction.
Not a fit: Patients with schizophrenia who do not exhibit cognitive dysfunction may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments targeting the specific neural alterations associated with schizophrenia.
How similar studies have performed: Previous research has shown that understanding GABA neuron alterations can provide valuable insights into schizophrenia, suggesting that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Fish, Kenneth N — University of Pittsburgh at Pittsburgh
- Study coordinator: Fish, Kenneth N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.